973 related articles for article (PubMed ID: 19939210)
21. CRH in Cushing's syndrome.
Müller OA; Stalla GK; von Werder K
Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
[TBL] [Abstract][Full Text] [Related]
22. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
[TBL] [Abstract][Full Text] [Related]
23. The medical treatment of Cushing's syndrome.
Miller JW; Crapo L
Endocr Rev; 1993 Aug; 14(4):443-58. PubMed ID: 7693447
[No Abstract] [Full Text] [Related]
24. [Cushing's syndrome: review of a national caseload].
Contreras P; Araya V
Rev Med Chil; 1995 Mar; 123(3):350-62. PubMed ID: 8525177
[TBL] [Abstract][Full Text] [Related]
25. Corticotropin-dependent Cushing's syndrome in older people: presentation of five cases and therapeutical use of ketoconazole.
Berwaerts JJ; Verhelst JA; Verhaert GC; Verhaegen AA; Abs RE
J Am Geriatr Soc; 1998 Jul; 46(7):880-4. PubMed ID: 9670876
[TBL] [Abstract][Full Text] [Related]
26. [Clinical usefulness of pharmacological treatment of Cushing's syndrome].
Saito J; Nishikawa T
Nihon Rinsho; 1994 Mar; 52(3):793-6. PubMed ID: 8164384
[TBL] [Abstract][Full Text] [Related]
27. What is the role of medical therapy in adrenal-dependent Cushing's syndrome?
Braun LT; Reincke M
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101376. PubMed ID: 32063487
[TBL] [Abstract][Full Text] [Related]
28. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
29. Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature.
Berwaerts J; Verhelst J; Mahler C; Abs R
Gynecol Endocrinol; 1999 Jun; 13(3):175-82. PubMed ID: 10451809
[TBL] [Abstract][Full Text] [Related]
30. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease.
Lankford HV; Tucker HS; Blackard WG
N Engl J Med; 1981 Nov; 305(21):1244-8. PubMed ID: 6270557
[TBL] [Abstract][Full Text] [Related]
31. New perspectives in the treatment of Cushing's syndrome.
Labeur M; Arzt E; Stalla GK; Páez-Pereda M
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Dec; 4(4):335-42. PubMed ID: 15578985
[TBL] [Abstract][Full Text] [Related]
32. The medical management of Cushing's syndrome during pregnancy.
Lim WH; Torpy DJ; Jeffries WS
Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):1-6. PubMed ID: 23305861
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
Daniel E; Aylwin S; Mustafa O; Ball S; Munir A; Boelaert K; Chortis V; Cuthbertson DJ; Daousi C; Rajeev SP; Davis J; Cheer K; Drake W; Gunganah K; Grossman A; Gurnell M; Powlson AS; Karavitaki N; Huguet I; Kearney T; Mohit K; Meeran K; Hill N; Rees A; Lansdown AJ; Trainer PJ; Minder AE; Newell-Price J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4146-54. PubMed ID: 26353009
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological management of Cushing's syndrome: an update.
Dang CN; Trainer P
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1339-48. PubMed ID: 18209872
[TBL] [Abstract][Full Text] [Related]
35. [Cushing's syndrome. II. New forms of treatment].
van Aken MO; Feelders RA; van der Lely AJ; Romijn JA; Lamberts SW; de Herder WW
Ned Tijdschr Geneeskd; 2006 Oct; 150(43):2365-9. PubMed ID: 17100127
[TBL] [Abstract][Full Text] [Related]
36. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells.
Lamberts SW; Bons EG; Bruining HA; de Jong FH
J Pharmacol Exp Ther; 1987 Jan; 240(1):259-64. PubMed ID: 3027305
[TBL] [Abstract][Full Text] [Related]
38. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.
Kreutzer J; Jeske I; Hofmann B; Blumcke I; Fahlbusch R; Buchfelder M; Buslei R
Clin Neuropathol; 2009; 28(6):430-9. PubMed ID: 19919817
[TBL] [Abstract][Full Text] [Related]
39. Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery.
Barbetta L; Dall'Asta C; Re T; Colombo P; Travaglini P; Ambrosi B
Horm Metab Res; 2001 Oct; 33(10):596-601. PubMed ID: 11607879
[TBL] [Abstract][Full Text] [Related]
40. Potential indications for somatostatin analogs in Cushing's syndrome.
Arnaldi G; Polenta B; Cardinaletti M; Boscaro M
J Endocrinol Invest; 2005; 28(11 Suppl International):106-10. PubMed ID: 16625858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]